Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2003
05/08/2003CA2464031A1 Purine analogs having hsp90-inhibiting activity
05/08/2003CA2463823A1 Aminobenzamide derivatives as glycogen synthase kinase 3.beta. inhibitors
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463770A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2462206A1 Substituted thioacetamides
05/08/2003CA2460134A1 Peroxisome proliferator activated receptor ligand and process for producing the same
05/08/2003CA2460118A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
05/08/2003CA2426785A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/07/2003EP1308513A1 Use of polypeptide
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308441A1 2-aminopyridine compounds and use thereof as drugs
05/07/2003EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307748A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
05/07/2003EP1307580A1 Koji molds and use thereof for preparing cholesterol-lowering products
05/07/2003EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307546A2 Ampk-related serine/threonine kinase, designated snark
05/07/2003EP1307480A2 Mutant trichosanthin
05/07/2003EP1307471A1 16alpha-methyl or ethyl substituted estrogens
05/07/2003EP1307468A1 Macrolide antibiotics
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307461A2 Substituted pyrrole compounds and their use as spla2 inhibitors
05/07/2003EP1307459A2 Indole compounds useful for the treatment of cancer
05/07/2003EP1307458A1 Pyrrolotriazolopyrimidinone derivatives
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307452A1 Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase
05/07/2003EP1307450A2 2-(4-pyrdyl)amino-6-dialkoxyphenyl-pyrido(2.3-d)pyrimidin-7-ones
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307446A1 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307439A2 Synthetic salicylihalamides, apicularens and derivatives thereof
05/07/2003EP1307432A1 Cyclic oxyguanidine protease inhibitors
05/07/2003EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307245A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
05/07/2003EP1307238A2 Contrast medium for medical diagnostics
05/07/2003EP1307229A1 Combination preparation with an er-beta selective estrogen and a serm or antiestrogen
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1307223A1 Parenteral vaccine formulations and uses thereof
05/07/2003EP1307213A2 Chlorella preparations exhibiting immunomodulating properties
05/07/2003EP1307206A2 Method for enhancing bone mineral density gain by administration of raloxifene
05/07/2003EP1307205A2 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1307202A1 Method for the treatment of overactive bladder
05/07/2003EP1307201A2 Selective pde 2 inhibitors, used as medicaments for improving cognition
05/07/2003EP1307200A2 Substituted-triazolopyrimidines as anticancer agents
05/07/2003EP1307199A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
05/07/2003EP1307198A1 Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase
05/07/2003EP1307197A2 Compositions for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide
05/07/2003EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
05/07/2003EP1307195A2 Medicaments containing cilansetron for treating non-obstipated male ibs patients
05/07/2003EP1307193A1 Agonists of follicle stimulating hormone activity
05/07/2003EP1307192A1 New use of angiotensin ii antagonists
05/07/2003EP1307190A1 Use of il-8 receptor antagonists in the treatment of virus infections
05/07/2003EP1307188A1 Cannabinoid drugs
05/07/2003EP1307186A1 Methods for decreasing cell proliferation based on (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
05/07/2003EP1307183A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
05/07/2003EP1307182A2 Pharmaceutical composition for transdermal delivery of befloxatone
05/07/2003EP1307108A2 Oil/fat composition
05/07/2003EP1216043B1 Retard form containing alpha-lipoic acid (derivatives)
05/07/2003EP1204658B1 Benzofurylpiperazine serotonin agonists
05/07/2003EP1152004B1 Phosphonic acid derivatives having carboxypeptidase B inhibitory action
05/07/2003EP1147110B1 Pyrazino(aza)indole derivatives
05/07/2003EP1140825B1 Melatonin derivatives and medicine containing same
05/07/2003EP1137433B1 Pharmaceutical compositions containing protein-disulfide isomerases
05/07/2003EP1058681B1 Novel allylthiopyridazine derivatives and process for preparing the same
05/07/2003EP1054863B1 2-aminoquinoline derivatives having d4-agonistic activity
05/07/2003EP1032414B1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
05/07/2003EP1019358B1 3,3-diarylpropylamines , their use and preparation
05/07/2003EP1001956B1 2,3-benzodiazepine derivatives
05/07/2003EP0912520B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
05/07/2003EP0889880B1 Eprosartan dihydrate and a process for its production and formulation
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0869791B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0831893B1 Regulation of neutrophil elastase synthesis and release
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0751765B1 Sulfonamide derivatives and their use
05/07/2003EP0749417B1 Cyano compounds and preparations thereof
05/07/2003CN1416464A Alpha-amylase activity inhibitors
05/07/2003CN1416431A Nucleoside compounds and uses thereof
05/07/2003CN1416430A 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents
05/07/2003CN1416425A 1,5-bemzothiazepines and their use as hypolipidaemics
05/07/2003CN1416424A Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
05/07/2003CN1416423A 2,4,Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1416420A 1,2,3,4-tetrahydroisoquinoline derivatives
05/07/2003CN1416351A HIV immune adjuvant therapy
05/07/2003CN1416346A Peotease inhibitors
1 ... 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 ... 1564